According to MarketsandMarkets™, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...
According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
The use of next-generation sequencing (NGS) technologies to detect B-cell receptor (BCR) or T-cell receptor (TCR) clonotypes ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
Companies unite in shared vision of enabling researchers to translate genomic insights to groundbreaking discoveries Partnership includes launch of new IDT xGen™ NGS products designed exclusively for ...
As next-generation sequencing (NGS) applications expand, researchers face growing pressure to generate accurate, uniform data from increasingly complex and low input samples.
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...
China's newly revised Frontier Health and Quarantine Law, which was implemented last year, included the Nipah virus in its ...
According to MarketsandMarkets, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in 2025 to USD 29.53 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results